期刊文献+

茶树菇凝集素检测醋酸格拉替雷诱导小鼠的CD8~+T淋巴细胞表面糖基化研究 被引量:1

Detection of Surface Glycosylation of CD8^+T Lymphocytes in Glatiramer Acetate-treated Mice, Using Agrocybe aegerita Lectins
原文传递
导出
摘要 醋酸格拉替雷是治疗多发性硬化症的一线药物,可通过诱导调节性CD8+T细胞发挥免疫调节作用。为研究GA诱导的CD8+T淋巴细胞,我们将茶树菇分离的两种凝集素AAL(Agrocybe aegerita lectin)和AAL2(Agrocybe aegerita lectin 2),通过生物素标记结合流式细胞仪,分别分析GA诱导的免疫耐受小鼠模型中脾脏、腹股沟淋巴结CD8+T淋巴细胞的糖基化水平,及细胞因子的表达。发现脾脏AAL+CD8+,AAL2+CD8+T淋巴细胞的比例(%)分别为8.46±3.1和9.08±2.8,淋巴结AAL+CD8+,AAL2+CD8+T淋巴细胞的比例(%)分别为10.65±4.6和8.25±5.9,且脾脏、淋巴结CD8+T淋巴细胞中AAL+细胞的百分比均显著高于CD8-T淋巴细胞(p<0.05)。淋巴结中AAL+CD8+T细胞表达IFN-γ的细胞比例显著高于AAL-CD8+T细胞,AAL2+CD8+T细胞表达IFN-γ和perforin细胞比例均显著高于AAL2-CD8+T细胞。该结果为CD8+T淋巴细胞表面糖基化研究提供了初步数据,并暗示糖基化水平与细胞因子分泌有关。 Glatiramer acetate(GA) is a first-line agent for the treatment of multiple sclerosis, and it exerts an immunomodulatory function by inducing regulatory CD8+ T cells. In order to investigate GA-induced CD8+ T cells, the lectins AAL(Agrocybe aegerita lectin) and AAL2 were used to analyze the glycosylation level and cytokine expression in CD8+ T lymphocytes in the spleen and inguinal lymph nodes in GA-induced, immune-tolerant mice, by biotin-labeling and flow cytometry. The results showed that the percentages of AAL+CD8+ and AAL2+CD8+ T lymphocytes in the spleen were 8.46 ± 3.1% and 9.08 ± 2.8%, respectively; and the percentages of AAL+CD8+ and AAL2+CD8+T lymphocytes in the inguinal lymph nodes were 10.65 ± 4.6% and 8.25 ± 5.9%, respectively. Moreover, the percentages of AAL+ cells in CD8+T lymphocytes in both the spleen and inguinal lymph nodes were significantly higher than those in the CD8- T lymphocytes(p 0.05). In the inguinal lymph nodes, the proportion of AAL+CD8+ T cells expressing IFN-γ was significantly higher than that of AAL-CD8+ T cells, and the proportion of cells expressing IFN-γ+ and perforin in AAL2+CD8+ T cells was also significantly higher than that in AAL2-CD8+ T cells. These studies provide preliminary data for studies on the surface glycosylation of CD8+ T lymphocytes, and indicate that glycosylation level is associated with cytokine secretion.
出处 《现代食品科技》 EI CAS 北大核心 2016年第5期9-13,8,共6页 Modern Food Science and Technology
基金 国家自然科学基金(81102850) 省卫生厅基金(A2011434) 省教育厅育苗工程(LYM11070) 东莞市科技局项目(2011108102049) 湛江市科技攻关项目(2011C3109015) 广东医学院大学生创新实验项目(2013ZYDC004)
关键词 糖基化 茶树菇半乳糖凝集素 CD8+T淋巴细胞 醋酸格拉替雷 glycosylation Agrocybe aegerita galectin CD8+ T lymphocyte glatiramer acetate
  • 相关文献

参考文献14

  • 1ALTELAAR A F, MUNOZ J, HECK A J. Next-generation proteomics: towards an integrative view of proteome dynamics [J]. Nature Reviews Genetics, 2013, 14(1): 35-48.
  • 2MOREMEN K W, TIEMEYER M, NAIRN A V. Vertebrate protein glycosylation: diversity, synthesis and function [J]. Nature Reviews Molecular Cell Biology, 2012, 13(7): 448- 462.
  • 3BRAAKMAN I, BULLED N J. Protein folding and modification in the mammalian endoplasmic reticulum [J]. Annual Review of Biochemistry, 2011: 8071-99.
  • 4RABINOVICH G A, CROCI D O. Regulatory circuits mediated by lectin-glycan interactions in autoimmtmity and cancer [J]. Immunity, 2012, 36(3): 322-335.
  • 5YI W, CLARK P M, MASON D E, et al. Phosphofi-uctokinase 1 Glycosylation Regulates Cell Growth and Metabolism [J]. Science, 2012, 337(6097): 975-980.
  • 6SINHA S, ITANI F R, KARANDIKAR N J. Immtme regulation of multiple sclerosis by Cd8 T cells [J]. Immunologic Research, 2014, 59(1-3): 254-265.
  • 7TYLER A F, MENDOZA J P, FIRAN M, et al. Cd8 T cells are required for glatiramer acetate therapy in autoimmune demyelinating disease [J]. PloS One, 2013, 8(6): e66772.
  • 8YAO Y, HAN W, LIANG J, et al. Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted Cd8(+) regulatory cells [J]. Eur. J lmmunol., 2013, 43(1): 125-136.
  • 9LIANG Y, CHEN H, ZHANG H B, et al. Lectin from agrocybe aegerita as a glycophenotype probe for evaluation of progression and survival in colorectal cancer [J]. Asian Pacific Journal of Cancer Prevention, 2014, 15(14): 5601- 5605.
  • 10JIANG Shuai, CHEN Yi-jie, WANG Man et al. A novel lectin from agrocybe aegerita shows high binding selectivity for terminal N-acetylglucosamine [J]. Biochem J., 2012, 443(2): 369-378.

二级参考文献15

  • 1卞冬萍,杨振泉,方维明.灰树花胞外多糖特性研究进展[J].现代食品科技,2006,22(3):247-250. 被引量:4
  • 2BORCHERS Andrea T, KEEN Carl L, GERSHWIN M Eric. Mushrooms, tumors, and immunity: an update [J]. Experimental Biology and Medicine (Maywood), 2004, 229(5): 393-406.
  • 3ZAIDMAN Ben-Zion, YASSIN Majed, MAHAJNA Jamal, et al. Medicinal mushroom modulators of molecular targets as cancer therapeutics [J]. Applied Microbiology and Biotechnology, 2005, 67(4): 453-468.
  • 4LIANG Yi, CHEN Yijie, LIU Honghong, et al. The tumor rejection effect of protein components from medicinal fungus [J]. Biomedicine & Preventive Nutrition, 2011,1 (4): 245-254.
  • 5Liang Yi, CHEN -ijie, SUN Hui. Antiturnor activity of protein component fraction and small molecule component fraction from agrocybe aegerita through enhancement of different cytokine production [J]. Journal of Medicinal Food, 2014, DOI 10.1089/jmf.2013.2846.
  • 6ASSELIN Barbara L. The three asparaginases, comparative pharmacology and optimal use in childhood leukemia [J]. Advances in Experimental Medicine and Biology, 1999, 457: 621-629.
  • 7DRUCKER Daniel J, BUSE John B, TAYLOR Kristin, et al.Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study [J]. Lancet, 2008, 372(9645): 1240-1250.
  • 8LI Jin-hua, KING Ada V, STICKEL Sara L, et al. Whole tumor cell vaccine with irradiated s180 cells as adjuvant [J]. Vaccine, 2009, 27(4): 558-564.
  • 9MORTON Donald L, EILBER Friedman R, MALMGREN Richard A, et al. Immunological factors which influence response to immunotherapy in malignant melanoma [J]. Surgery, 1970, 68(1): 158-163.
  • 10CHEN Shi-an, TSAI Ming-huan, WU Fu-tien, et al. Induction of antitumor immunity with combination of her2/neu dna vaccine and interleukin 2 gene-modified tumor vaccine [J]. Clinical Cancer Research, 2000, 6(11): 4381-4388.

共引文献9

同被引文献31

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部